TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm” or the “Company”) (TSX VENTURE:EKG) is pleased to announce that it held business meetings with 25 technology companies during an Ontario Trade Delegation visit to Japan and Korea from February 20 to 27. The meetings were arranged through the assistance of the Ontario Ministry of International Trade with Global Affairs Canada representatives in Japan and Korea, the Osaka Prefecture Government, Economic Affairs Government of Ontario at the Embassy of Canada to Korea, Intralink Limited and direct marketing efforts by CardioComm. The Company confirmed the likelihood of letters of intent and cooperation agreements to result over the next few months.

CardioComm used this Trade Mission to: (1) meet with regional device manufacturers interested in HeartCheck™ compatibility certification; (2) pursue telemedicine partnership opportunities at a time when Japan is implementing new telemedicine initiatives; and, (3) demonstrate near-real-time remote patient monitoring using the Company’s SMART Monitoring ECG reading telemedicine technology and its newest wireless consumer and hospital use ECG /arrhythmia monitoring Bluetooth connected devices.

The Company provided attendees at the Japan Medical 2018 exhibition a preview of the Company’s pipeline of up and coming wirelessly connected devices which includes 12 lead ECG SMART shirts, ECG sensing fitness bands, handheld devices and a 12 lead ECG chest band. These devices are already pre-qualified as HeartCheck™ compatible and have connectivity to CardioComm’s GEMS™ Mobile Smartphone ECG management app and to its GEMS™ software platform which is currently utilized by hospitals across the USA and Canada.

The Company also demonstrated its GEMS™ Mobile Rx app intended for use by physicians on Android and iOS based Smartphones and tablets. GEMS™ Mobile Rx enables healthcare professionals to now use ECG interrogation tools previously available only on the server based GEMS™ WIN hospital software on their own Smartphone without the need for accessing CardioComm’s cloud based SMART Monitoring ECG service. If a second opinion is required, an ECG review through SMART Monitoring is available. For Windows based Smartphones and computers the Company will release GEMS™ Home Rx.

CardioComm continued discussions with Intralink Limited who assisted in coordinating many of the business-to-business meetings during the Japanese leg of the Trade Mission. Intralink offers a range of pre- and post-market entry services, including market research and strategy development, partner search and selection, and local representation. Intralink works with clients to commercialize technology, secure foreign direct investment, and source capital from strategic investors. The medical market in Japan provides a large opportunity to introduce North American standards for cardiac outpatient monitoring. In Japan there are approximately 100,955 medical clinics and 1.5 million hospital beds in 8,480 hospitals (2015 statistics, Directives issued under the Japanese Health, Labor and Welfare Ministry are introducing new medical fee reimbursements related to the implementation of telemedicine platforms with an effective date of April 1, 2018. The new reimbursement fees will support Japan’s efforts to encourage doctors to offer medical counseling over the internet. Of specific relevance to CardioComm is the implementation of a new telemedicine fee for mobile ECG monitoring at a value of 1500 JPY per ECG (approximately Cdn$18.29).

The Company will provide further updates as they are realized.

To learn more about the CardioComm Solutions’ products, please see the Company’s websites and or contact the Company at